Indegene Limited

Indegene Limited

Indegene Limited has informed the Exchange about the preliminary approval of a proposed class action settlement against its wholly-owned overseas subsidiary, Indegene, Inc., before the U.S. District Court, District of New Jersey. The settlement remains subject to completion of the notice and claims process and final approval by the Court.

Indegene Limited

Indegene Limited has informed the Exchange about the schedule of an investor/analyst meeting to be held on August 24 and 25, 2026, for various investors and analysts. The meeting will be held online or in-person in Bengaluru, and no unpublished price-sensitive information will be shared.

Indegene Limited

Indegene Limited has informed the Exchange about the pendency of litigation involving its wholly-owned subsidiary, Indegene, Inc., in the U.S. District Court, District of New Jersey. The lawsuit relates to alleged violations of the U.S. Telephone Consumer Protection Act, 1991. The parties have concluded negotiations on the definitive settlement agreement, subject to execution by the relevant parties and approval of the U.S. District Court.

Indegene Limited

Indegene Limited has held its 28th Annual General Meeting through video conference, with the Chairman and Directors introducing themselves and confirming the quorum is present.

Indegene Limited

Indegene Limited has informed the Exchange regarding Change in Director(s) of the company. Ms. Jill Mary De Simone has been appointed as an Independent Director for a term of 3 years.

Indegene Limited

Indegene Limited has submitted the Exchange a copy of the Scrutinizers report of Annual General Meeting held on August 13, 2026, and informed the Exchange regarding voting results.

Indegene Limited

Indegene Limited has informed the Exchange about a scheduled investor/analyst meeting on August 19, 2026, in Mumbai, where no unpublished price-sensitive information will be shared.

Indegene Limited

Indegene Limited has held its 28th Annual General Meeting (AGM) on August 13, 2026, through video conferencing. The meeting was attended by the Chairman, Executive Director, and Chief Executive Officer, along with other key management personnel and statutory auditors. The proceedings were video recorded and webcast on the National Depository System Limited's website. The company secretary briefed members on the e-voting process and the scrutinizer was appointed to ensure a fair and transparent process.

Indegene Limited

Indegene Limited has informed the Exchange about Schedule of meet for Investor / Analyst meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Indegene Limited

Indegene Limited has informed the Exchange about a scheduled meeting with investors and analysts.

Indegene Limited

Indegene Limited has informed the Exchange about the transcript of the conference call for the quarter ended June 30, 2026, held on July 31, 2026. The company's Chairman and CEO, Mr. Manish Gupta, and CFO, Mr. Suhas Prabhu, discussed the highlights of the business and financials of the quarter. The transcript will be available on the company's website in a week's time.

Indegene Limited

Indegene Limited has published its standalone and consolidated audited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 8,682.13 lakhs and Rs. 41,321.78 lakhs respectively.

Indegene Limited

Indegene Limited has made available the audio recording of its earnings call for the quarter ended June 30, 2026, on its website and IR website.

Indegene Limited

Indegene Limited has reported Q1 FY'27 results with 39.7% YoY revenue growth in INR terms and 26.5% in USD. The company expanded its active client base to 105 and improved productivity with revenue per employee rising to $77K.

Indegene Limited

Indegene Limited has announced its financial results for the quarter ended June 30, 2026, with revenue up 39.7% YoY and PAT up 45.9% QoQ.

Indegene Limited

Indegene Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations. The report covers the utilization of the issue proceeds in relation to the objects of the issue. The monitoring agency, Care Edge Ratings, has declared that the report provides an objective view of the utilization of the issue proceeds based on the information provided by the issuer and information obtained from sources believed to be accurate and reliable.

Indegene Limited

Indegene Limited has informed the Exchange regarding allotment of 12451 securities pursuant to ESOP/ESPS and approval of unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Indegene Limited

Indegene Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the auditor's review report. The results include the unaudited financial information of 1 subsidiary and 10 step-down subsidiaries, with no material misstatements found.

Indegene Limited

Indegene Limited has informed the Exchange about a copy of newspaper publication regarding e-voting information for the 28th Annual General Meeting of the Company scheduled to be held on August 13, 2026.

Indegene Limited

Indegene Limited has informed the Exchange about Letter to Shareholders in relation to Annual Report of the Company for the financial year 2025-26. The company has initiated dispatch of letters to those Shareholders whose e-mail IDs are not registered with Company/Registrar & Transfer Agent/Depository Participants, providing the weblink of Company’s website from where the Annual Report for FY 2025-26 can be accessed. The company has also scheduled the 28th Annual General Meeting (“AGM”) of the Members of Indegene Limited (“the Company”) to be held on Thursday, 13 August 2026 at 16:30 hours IST through Video Conference (“VC”)/ Other Audio Visual Means (“OAVM”).